A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC
Clinical trial NCT04398108 · COMPLETED
Trial details
- NCT number
- NCT04398108
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2021-04-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.